LISTEN LIVE: All Things Considered
LISTEN LIVE: All Things Considered

Advertisement

FDA Advisory Panel Rejects Controversial Alzheimer's Drug03:36
Download

Play

A Food and Drug Administration advisory committee voted that studies of the drug aducanumab for Alzheimer's treatment don't show it's effective.

Advertisement

Advertisement

/00:00
Close